Haemoglobinopathies: screening by capillary electrophoresis

The two major roles of the haemoglobinopathy laboratory are the recognition of clinically important variant haemoglobins and the accurate and precise quantification of haemoglobin A2 for the diagnosis of β-thalassaemia heterozygosity. Both can be met by capillary electrophoresis (CE), which is now regarded as a suitable technique for the diagnosis of β-thalassaemia and the detection of variant haemoglobins.

In the August issue of Pathology in Practice, the experiences of four hospital sites (Royal Hallamshire Hospital, Sheffield; Hereford County Hospital; South West London Pathology; and Birmingham Women’s Hospital) now using CE as a front-line method in the diagnosis of haemoglobinopathies will be featured, along with the advantages offered by Sebia Capillarys instruments.



Other news

Upcoming Events

Biosafety Practitioner Level 1 Training Course

Public Health England
15-19 January 2018

British Society for Microbial Technology Annual Scientific Conference

Public Health England, Colindale, London
18 May 2018

Pathology Horizons 2018 Conference

Lough Erne Resort, Co. Fermanagh, Northern Ireland
September 13-15

Microbe 2018

Hilton Hotel, Sheffield
21-23 September 2018

Latest Issue

Pathology In Practice

Pathology In Practice

Aug 2017

Screening for haemoglobinopathies

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.